Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Delcath Systems (DCTH) Long-Term Debt Repayments (2022 - 2024)

Delcath Systems' quarterly Long-Term Debt Repayments came in at $2.0 million in Q4 2024, down 20.1% quarter-over-quarter from $2.5 million in Q3 2024.

Delcath Systems has reported Long-Term Debt Repayments for 3 years, with the latest figure at $2.0 million in Q4 2024.

  • For the quarter ending Q4 2024, Long-Term Debt Repayments changed N/A year-over-year to $2.0 million; the trailing twelve-month figure through Sep 2025 stood at $2.0 million (down 76.77% YoY), and the FY2024 full-year result was $10.6 million, up 68.07% from the prior year.
  • Long-Term Debt Repayments for Q4 2024 stood at $2.0 million, down from $2.5 million in the prior quarter.
  • The five-year high for Long-Term Debt Repayments was $6.3 million in Q1 2023, with the low at $714000.0 in Q4 2022.
  • Average Long-Term Debt Repayments over 3 years is $2.9 million, with a median of $2.8 million recorded in 2024.
  • Peak annual rise in Long-Term Debt Repayments reached 51.62% in 2024, while the deepest fall reached 51.62% in 2024.
  • Tracing DCTH's Long-Term Debt Repayments over 3 years: stood at $714000.0 in 2022, then soared by 784.17% to $6.3 million in 2023, then plunged by 68.32% to $2.0 million in 2024.
  • The last three Long-Term Debt Repayments figures came in at $2.0 million (Q4 2024), $2.5 million (Q3 2024), and $3.1 million (Q2 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Repayments (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 1.42 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 1.00 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Delcath Systems 383.27 Mn 293.95 Mn 21.26 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2024 2.00 Mn
Dec 31, 2024 2.00 Mn
Sep 30, 2024 2.50 Mn
Sep 30, 2024 2.50 Mn
Jun 30, 2024 3.05 Mn
Jun 30, 2024 3.05 Mn
Mar 31, 2024 3.05 Mn
Mar 31, 2024 3.05 Mn
Mar 31, 2023 6.31 Mn
Mar 31, 2023 6.31 Mn
Dec 31, 2022 714,000.00
Dec 31, 2022 714,000.00